Paper17519900
Mechanisms of adverse effects of anti-VEGF therapy for cancer.
Kamba T and 1 other. Br J Cancer, 2007. Cited by 788 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Papers, record 17519900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519900
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Angiogenesis Inhibitors | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Agents | |
| Benzenesulfonates | |
| Bevacizumab | |
| Hemorrhage | |
| Humans | |
| Indoles | |
| Niacinamide | |
| Phenylurea Compounds | |
| Pyridines | |
| Pyrroles | |
| Signal Transduction | |
| Sorafenib | |
| Sunitinib | |
| Thrombosis | |
| Wound Healing |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL024136 | NHLBI NIH HHS | United States | P01HL024136 | PubMed and NIH | NIH RePORTER |
| R01 CA082923 | NCI NIH HHS | United States | R01CA082923 | PubMed and NIH | NIH RePORTER |
| HL59157 | NHLBI NIH HHS | United States | R01HL059157 | PubMed and NIH | NIH RePORTER |
| R01 HL059157 | NHLBI NIH HHS | United States | R01HL059157 | PubMed and NIH | NIH RePORTER |
| CA082923 | NCI NIH HHS | United States | R01CA082923 | PubMed and NIH | NIH RePORTER |
| HL24136 | NHLBI NIH HHS | United States | P01HL024136 | PubMed and NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15215160 | Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15215160 | PubMed |
| 2 | 16784838 | VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/16784838 | PubMed |
| 3 | 15001532 | Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. | Circ Res | 2004 | https://conductscience.org/library/papers/15001532 | PubMed |
| 4 | 16799557 | VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. | Nat Med | 2006 | https://conductscience.org/library/papers/16799557 | PubMed |
| 5 | 15149314 | The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. | Kidney Int | 2004 | https://conductscience.org/library/papers/15149314 | PubMed |
| 6 | 16880234 | Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions. | Oncologist | 2006 | https://conductscience.org/library/papers/16880234 | PubMed |
| 7 | 16126815 | Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. | Am J Physiol Heart Circ Physiol | 2006 | https://conductscience.org/library/papers/16126815 | PubMed |
| 8 | 16140331 | The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. | J Surg Res | 2005 | https://conductscience.org/library/papers/16140331 | PubMed |
| 9 | 17327610 | Sunitinib: from rational design to clinical efficacy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17327610 | PubMed |
| 10 | 16301833 | Managing patients treated with bevacizumab combination therapy. | Oncology | 2005 | https://conductscience.org/library/papers/16301833 | PubMed |
| 11 | 11350732 | Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. | Am J Physiol Cell Physiol | 2001 | https://conductscience.org/library/papers/11350732 | PubMed |
| 12 | 9409257 | Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. | Arterioscler Thromb Vasc Biol | 1997 | https://conductscience.org/library/papers/9409257 | PubMed |
| 13 | 17167137 | Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17167137 | PubMed |
| 14 | 12393615 | Polycythemia vera: myths, mechanisms, and management. | Blood | 2002 | https://conductscience.org/library/papers/12393615 | PubMed |
| 15 | 15175435 | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15175435 | PubMed |
| 16 | 12618525 | Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12618525 | PubMed |
| 17 | 17316891 | Chemotherapy induced reversible posterior leukoencephalopathy syndrome. | Lung Cancer | 2007 | https://conductscience.org/library/papers/17316891 | PubMed |
| 18 | 15169807 | Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15169807 | PubMed |
| 19 | 12086877 | VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12086877 | PubMed |
| 20 | 17030665 | Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. | Arch Neurol | 2006 | https://conductscience.org/library/papers/17030665 | PubMed |
Cited by436
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 788 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958672 | Integrative network pharmacology and experimental validation to decipher the anti-angiogenic mechanisms of Xuandan Sanjie decotion in adenomyosis. | J Tradit Chin Med | 2026 | https://conductscience.org/library/papers/42958672 | PubMed |
| 42861086 | Neurodevelopmental Disorders in Infants Treated with Anti-VEGF Agents versus Laser Photocoagulation or Cryotherapy for Retinopathy of Prematurity. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/42861086 | PubMed |
| 42820177 | Nintedanib-Associated Generalized Body Swelling in a Patient With Idiopathic Pulmonary Fibrosis: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42820177 | PubMed |
| 42780318 | A case of recurrent acute acalculous cholecystitis in a patient with renal cell carcinoma treated with pazopanib and axitinib: case report and literature review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42780318 | PubMed |
| 42649859 | The Role of Splicing Machinery as a Promising Potential Therapeutic Target for Pituitary Neuroendocrine Tumors (PitNETs). | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649859 | PubMed |
| 42464367 | Early-onset duodenal perforation during bevacizumab-containing chemotherapy in a patient with ovarian cancer: a case report. | J Pharm Health Care Sci | 2026 | https://conductscience.org/library/papers/42464367 | PubMed |
| 42305612 | DPPA inhibits melanoma by targeting angiogenesis through activating autocrine IFN-γ-CXCL9/10/11-CXCR3 axis in vascular endothelial cells. | iScience | 2026 | https://conductscience.org/library/papers/42305612 | PubMed |
| 42256328 | A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma. | IJU Case Rep | 2026 | https://conductscience.org/library/papers/42256328 | PubMed |
| 42138076 | Towards precision medicine for brain arteriovenous malformations. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42138076 | PubMed |
| 42122227 | Gastrointestinal and Variceal Bleeding Under Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: Evidence from Trials to Real-World Practice. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122227 | PubMed |
| 42017533 | Reversible sorafenib-associated coagulopathy identified by viscoelastic testing in a dog with intranasal sarcoma. | J Vet Intern Med | 2026 | https://conductscience.org/library/papers/42017533 | PubMed |
| 41939827 | Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41939827 | PubMed |
| 41893767 | Longitudinal Assessment of an 800 µg Dose of HEBERSaVax in Non-Human Primates over Six Months. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893767 | PubMed |
| 41765886 | Efficacy and safety of atezolizumab combined with bevacizumab-based chemotherapy in advanced malignancies: a systematic review and meta-analysis of randomized trials. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41765886 | PubMed |
| 41716992 | SHP2 regulates VEGFR2 Y1175/PLCγ signaling to impair tumor endothelial barrier stability. | iScience | 2026 | https://conductscience.org/library/papers/41716992 | PubMed |
| 41676232 | Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection. | Oncoscience | 2026 | https://conductscience.org/library/papers/41676232 | PubMed |
| 41602381 | Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/41602381 | PubMed |
| 41350916 | Long non-coding RNAs and VEGF in ovarian cancer: mechanisms and therapeutic potential. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/41350916 | PubMed |
| 41257900 | Cold atmospheric plasma is a promising strategy for treating diabetic retinopathy. | J Transl Med | 2025 | https://conductscience.org/library/papers/41257900 | PubMed |
| 41226782 | A Stable RNA Vaccine Against the Regulatory Peptide Adrenomedullin Reduces Angiogenesis and Tumor Burden in a Subcutaneous Melanoma Model Without Inducing an Immunosuppressive Tumor Microenvironment. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226782 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| FLT1 | 2321 | PubTator's text mining | https://conductscience.org/library/genes/2321 | NCBI Gene |
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| FLT4 | 2324 | PubTator's text mining | https://conductscience.org/library/genes/2324 | NCBI Gene |
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| KIT | 3815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| PDGFRB | 5159 | PubTator's text mining | https://conductscience.org/library/genes/5159 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17519900
GET https://conductscience.org/api/papers/v1/17519900/references?page=2